Dong, Xianjun http://orcid.org/0000-0002-8052-9320
Bai, Yunfei http://orcid.org/0000-0002-4088-4117
Liao, Zhixiang
Gritsch, David
Liu, Xiaoli
Wang, Tao http://orcid.org/0000-0002-5728-6463
Borges-Monroy, Rebeca http://orcid.org/0000-0001-5821-7630
Ehrlich, Alyssa
Serrano, Geidy E.
Feany, Mel B. http://orcid.org/0000-0003-0315-7970
Beach, Thomas G.
Scherzer, Clemens R. http://orcid.org/0000-0002-0567-9193
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 AG057331, U01 NS082157)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
American Parkinson’s Disease Association, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Aligning Science Across Parkinson’s
Article History
Received: 8 November 2022
Accepted: 20 July 2023
First Online: 18 September 2023
Competing interests
: C.R.S. has served as consultant, scientific collaborator or on scientific advisory boards for Sanofi, Berg Health, Pfizer, Biogen, and has received grants from NIH, U.S. Department of Defense, APDA, ASAP, and MJFF. X.D. has received funding from NIH, APDA, and ASAP. The other authors declare no competing interests.